Supraorbital Basosquamous Carcinoma Treated with Cemiplimab Followed by Sonidegib: A Case Report and Review of the Literature.

Biomedicines · 2023 · PMC10669660 · PMID 38001904

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The study showed a trend between aggressive histology subtypes and response to therapy, with the basosquamous variant having the greatest response to anti-PD-1 [ 40 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.